Pharma
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Selected Work

Global Companion Diagnostic Guideline Mapping and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy

Synthetic mRNA Production Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Market Landscaping and Sizing

Internal Lab Buildout Strategy
Voice-of-Customer Research
Due Diligence






.png)
.png)



